Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2023-04-14 | Carrie Eglinton Manner has been our President, CEO and a member of the Board since June 2022. Ms. Eglinton Manner brings more than 25 years of healthcare leadership and transformation expertise to the Company. Prior to joining the Company, Ms. Eglinton Manner was with Quest Diagnostics Inc. from January 2017 until June 2022 where she served as Senior Vice President, Advanced & General Diagnostics Clinical Solutions. In that role, she was responsible for bringing innovative diagnostic solutions to market in the areas of women’s health, neurology, oncology, cardiovascular, metabolic, endocrinology, infectious disease, and immunology testing services, as well as drug monitoring and toxicology. Ms. Eglinton Manner also led Quest’s pharmaceutical services, AmeriPath/Dermpath, and international businesses, as well as their molecular genetics team in pioneering next-generation sequencing innovation. Prior to Quest Diagnostics, Ms. Eglinton Manner served for 20 years in a variety of leadership roles at GE Healthcare, a division of General Electric (GE). Ms. Eglinton Manner has served as a director of Repligen Corporation since June 2020. Ms. Manner received a B.S. degree in mechanical engineering from University of Notre Dame. |
| 2024-04-03 | Ms. Manner received a B.S. degree in mechanical engineering from University of Notre Dame. |
| 2025-04-04 | Ms. Manner received a B.S. degree in mechanical engineering from the University of Notre Dame. |
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-21 | Carrie Eglinton Manner has served as a director of Repligen since June 2020. She currently serves as Senior Vice President, Advanced Diagnostics at Quest Diagnostics. Ms. Eglinton Manner serves as a member of the Audit Committee. |
| 2022-04-11 | Carrie Eglinton Manner has served as a director of Repligen since June 2020. ... Ms. Eglinton Manner currently serves as Senior Vice President, Advanced & General Diagnostics and Clinical Solutions at Quest Diagnostics. ... The Audit Committee currently consists of Mr. Muir, Mr. Ryan and Ms. Eglinton Manner. Ms. Eglinton Manner replaced Ms. Dawes as a member of the Audit Committee in February 2021. ... Director Compensation Table for the Fiscal Year Ended December 31, 2021 shows total compensation $218,523. |
| 2023-04-11 | Carrie Eglinton Manner President and Chief Executive Officer, OraSure Technologies, Inc. 49 2020 ✓ - • 70,000 162,990 162,928 395,918 |
| 2024-04-01 | Carrie Eglinton Manner has served as a director of Repligen since June 2020. She brings to the director role over 25 years of leadership experience across multiple disciplines. |
| 2025-04-04 | Ms. Eglinton Manner holds a B.S. in Mechanical Engineering from the University of Notre Dame. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22